Stock 4593 HEALIOS K.K.
Add to a list
To use this feature you must be a member
Log inSign up

News Healios K.K.

Equities

4593

JP3835100003

Delayed Japan Exchange
Other stock markets
 10:27:34 2024-07-15 pm EDT 		5-day change 1st Jan Change
183 JPY 0.00% Intraday chart for Healios K.K. +7.02% +10.91%
Jun. 20 Healios to Book $3 Million Upfront Payment as Sales Revenue in Q2 Following License Deal with Astellas Institute MT
Jun. 19 Healios K.K. Enters into License Agreement with Astellas Institute for Regenerative Medicine CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Healios to Book $3 Million Upfront Payment as Sales Revenue in Q2 Following License Deal with Astellas Institute
MT
Healios K.K. Enters into License Agreement with Astellas Institute for Regenerative Medicine
CI
Healios Enters Alliance, Bond Purchase Deal with Alfresa
MT
Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen
MT
Healios K.K. Enters into Joint Research Agreement with AND Medical Group
CI
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP
MT
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .
CI
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data
MT
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation
MT
Jefferies Adjusts Healios K.K.’s Price Target at 140 Yen From 170 Yen, Keeps at Hold
MT
Healios K.K. announced that it has received ¥2.2600715 billion in funding
CI
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan
CI
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding
CI
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment
MT
Japanese Shares Finish Lower After Key Economic Data
MT
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan
CI
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal
MT
Healios Secures LOI on Joint Research with AND
MT
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research
CI
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4593 Stock
  4. News Healios K.K.